Physician profile
Jason E Lemoine
NPI 1154328375
$9,778.67
in general payments reported to CMS, 2019-2025
52 companies · $2,748 in 2025
The $2,748 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $920 · 2021: $1,184 · 2022: $1,191 · 2023: $1,862 · 2024: $1,261 · 2025: $2,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,770 · Travel and Lodging: $922 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,769.85 |
| Travel and Lodging | $921.76 |
| Education | $178.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $1,481.18 | 2020-2025 | Prolaris, Myrisk |
| Procept Biorobotics Corporation | $1,337.47 | 2024-2025 | Aquabeam System |
| Axonics, INC. | $991.80 | 2020-2024 | Axonics |
| Coloplast Corp | $979.97 | 2019-2025 | Speedicath |
| Boston Scientific Corporation | $619.92 | 2019-2025 | Lithovue, Axonics, Tria Firm |
| Sumitomo Pharma America, INC. | $591.93 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $450.19 | 2019-2023 | Myrbetriq |
| Ferring Pharmaceuticals INC. | $296.86 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $287.37 | 2022-2025 | Jelmyto |
| Allergan, INC. | $260.13 | 2019-2021 | |
| Pfizer INC. | $249.81 | 2019-2024 | |
| Calyxo, INC. | $247.43 | 2024-2025 | Cvac Aspiration System |
| Neotract INC. | $210.28 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $208.33 | 2020-2023 | Aveed, Xiaflex |
| Teleflex LLC | $205.97 | 2021-2023 | Urolift |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Lemoine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.